Bluebird Bio (BLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BLUE | AMGN | VRTX | REGN | BMY |
| Company | Bluebird Bio | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.9300 | 269.18 | 397.48 | 883.20 | 45.09 |
| High | 0.9779 | 276.36 | 399.31 | 897.78 | 45.38 |
| Low | 0.9136 | 268.99 | 394.35 | 883.20 | 44.53 |
| Last | 0.9121 | 276.28 | 395.49 | 890.75 | 44.65 |
| Change | -0.0107 | +6.30 | -1.99 | +7.55 | -0.20 |
| % Change | -1.16% | +2.33% | -0.50% | +0.85% | -0.45% |
| Volume | 4,654,370 | 1,446,201 | 383,940 | 237,637 | 11,211,033 |
| 20-Day Average Volume | 5,313,257 | 2,132,232 | 923,536 | 450,368 | 13,265,791 |
| Previous Close | 0.9228 | 269.98 | 397.48 | 883.20 | 44.85 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0641 | 269.61 | 400.02 | 914.61 | 49.05 |
| 20-Day Raw Stochastic | 10.55% | 64.01% | 14.07% | 17.74% | 3.33% |
| 20-Day Relative Strength | 38.46% | 51.22% | 40.94% | 36.65% | 28.65% |
| Weighted Alpha | -64.90 | +13.53 | +12.05 | +14.87 | -35.36 |
| Today's Opinion | 100% Sell | 24% Sell | 8% Sell | 8% Buy | 88% Sell |
| Previous Opinion | 100% Sell | 72% Sell | 8% Buy | 8% Sell | 88% Sell |
| Last Month's Opinion | 56% Sell | 24% Buy | 56% Buy | 80% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.29% since 04/22/24 | +1.34% since 04/22/24 | -1.18% since 04/22/24 | -1.06% since 04/22/24 | -9.16% since 04/22/24 |
| Low | 0.8812 on 04/25/24 | 265.72 on 04/26/24 | 393.00 on 04/25/24 | 875.22 on 04/26/24 | 44.34 on 04/26/24 |
| High | 1.0500 on 04/23/24 | 276.36 on 04/29/24 | 406.86 on 04/23/24 | 915.70 on 04/24/24 | 49.47 on 04/23/24 |
| 1-Month | |||||
| %Chg | -27.95% since 03/28/24 | -3.08% since 03/28/24 | -5.45% since 03/28/24 | -7.46% since 03/28/24 | -17.68% since 03/28/24 |
| Low | 0.8812 on 04/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 44.34 on 04/26/24 |
| High | 1.3000 on 04/01/24 | 283.91 on 04/02/24 | 421.45 on 04/01/24 | 970.20 on 04/01/24 | 54.23 on 04/01/24 |
| 3-Month | |||||
| %Chg | -18.39% since 01/29/24 | -12.09% since 01/29/24 | -9.32% since 01/29/24 | -6.82% since 01/29/24 | -10.49% since 01/29/24 |
| Low | 0.8790 on 02/06/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 44.34 on 04/26/24 |
| High | 1.9200 on 02/27/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -66.16% since 10/27/23 | +5.34% since 10/27/23 | +11.24% since 10/27/23 | +14.90% since 10/27/23 | -12.50% since 10/27/23 |
| Low | 0.8790 on 02/06/24 | 249.70 on 10/31/23 | 341.90 on 11/16/23 | 772.84 on 10/31/23 | 44.34 on 04/26/24 |
| High | 5.5300 on 12/08/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 100,895 | 144,810,784 | 102,732,288 | 96,941,800 | 90,900,144 |
| Shares Outstanding, K | 109,336 | 536,376 | 258,459 | 109,762 | 2,026,759 |
| Annual Sales | 3,600,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -266,580,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 12,390,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,477,000,000 |
| Last Quarter Net Income | -71,730,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | 1,762,000,000 |
| 60-Month Beta | 0.74 | 0.58 | 0.35 | 0.11 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.66 on 11/07/23 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/14/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.44 | 29.59 | 23.70 | 6.08 |